0001387131-23-007495.txt : 20230612 0001387131-23-007495.hdr.sgml : 20230612 20230612152127 ACCESSION NUMBER: 0001387131-23-007495 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 EFFECTIVENESS DATE: 20230612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-483973 FILM NUMBER: 231007847 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 D 1 primary_doc.xml X0708 D LIVE 0000887247 Adamis Pharmaceuticals Corp 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 (858) 997-2400 DELAWARE Cellegy Pharmaceuticals Inc. CELLEGY PHARMACEUTICALS INC Corporation true David J. Marguglio 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Ebrahim Versi 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Director David C. Benedicto 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Executive Officer Howard C. Birndorf 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Director Meera J. Desai 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Director Vickie S. Reed 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Director Jannine Versi 11682 El Camino Real, Suite 300 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2023-05-25 false true true true 0 Indefinite 0 Indefinite false 12 0 0 0 false Adamis Pharmaceuticals Corp /s/ David C. Benedicto David C. Benedicto Chief Financial Officer 2023-06-12